ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,329, issued on Dec. 2, was assigned to NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (Kobe, Japan) and DAIICHI SANKYO COMPANY Ltd. (Tokyo).

"Anti-SIRPAlpha antibody" was invented by Takashi Matozaki (Kobe, Japan), Mayumi Sue (Tokyo), Kensuke Nakamura (Tokyo) and Chigusa Yoshimura (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "An anti-SIRPAlpha antibody that can be used as a tumor agent and an anti-tumor agent comprising the antibody as an active ingredient. An antibody that binds specifically to human SIRPAlpha to inhibit binding of human SIRPAlpha to CD47."

The patent was filed on May 10, 2024, under Application No. 18/660,591.

*For furth...